NCAM1 and hepatocellular carcinoma: A decline in the CD56 dim NK are observed in circulating blood and in HCC tumour nodules, which suggests that the suppressed tumour-surveillance functions of NK cells is caused by a decline in the release of IFNγ and cytotoxic activity in HCC patients.